Autologous Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Wednesday, January 25, 2017 Research News
Email Print This Page Comment
Font : A-A+

LONDON, Jan. 24, 2017 /PRNewswire/ -- Global Autologous Cell Therapy Market: OverviewThis report provides

in-depth region wise and country wise analysis of the autologous cell therapy market. Stakeholders of this report include manufacturers of cell therapy products, raw material suppliers, cancer drug processing companies, and new players planning to enter
the market.The report provides qualitative and quantitative analysis of the global autologous cell therapy market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes major players with their reported revenue, market size, and forecast for the global autologous cell therapy market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Switzerland, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia. Market revenue is provided in terms of US$ Mn from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 for all the segments, considering 2015 as the base year. The executive summary of the report provides a snapshot of the autologous cell therapy with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors. Moreover, the report also includes pipeline analysis (phase I & II) of the autologous cell therapy market on basis of disease conditions.Global Autologous Cell Therapy Market: Drivers and TrendsThe market overview section comprises impact factors such as drivers, restraints, and opportunities for the global autologous cell therapy market. These factors would aid the stakeholders in establishing a strong foothold in the global autologous cell therapy market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the autologous cell therapy market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.Global Autologous Cell Therapy Market: SegmentationThe autologous cell therapy market has been segmented as source, application, end-user and geography. Based on source, the market has been segmented into bone marrow, epidermis and others. Likewise, on basis of application the market has been categorized into neurology, orthopedic, cancer, wound healing, CVD, autoimmune, and others. Hospitals, ambulatory centers and research centers are included into the market by end-user.Global Autologous Cell Therapy Market: Regional OutlookGeographically, the autologous cell therapy market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Switzerland, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the autologous cell therapy market in various regions has been provided in this section.This report also includes various ups and downs about particular country or geography that has impacted the overall market globally. The report provides a detailed outline/blueprint of the autologous cell therapy market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market.Key Players Mentioned in the Report are:The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include BIOTIME, INC., BrainStorm Cell Therapeutics, Caladrius Biosciences, Inc., Vericel Corporation, Pharmicell Co., Inc., TiGenix N.V., Fibrocell Science, Inc. and Opexa Therapeutics, Inc. among others.The global autologous cell therapy market has been segmented into:Global Autologous Cell Therapy Market, by SourceBone MarrowEpidermisOthersGlobal Autologous Cell Therapy Market, by ApplicationNeurologyOrthopedicCancerWound HealingCVDAutoimmuneOthersGlobal Autologous Cell Therapy Market, by End UserHospitalsAmbulatory CentersResearch CentersGlobal Autologous Cell Therapy Market, by GeographyNorth AmericaU.S.CanadaEuropeGermanyFranceU.K.SwitzerlandSpainRest of EuropeAsia Pacific (APAC)JapanChinaIndiaRest of APACLatin America (LATAM)BrazilMexicoRest of LATAMMiddle East & Africa (MEA)South AfricaSaudi ArabiaRest of MEA

Download the full report: https://www.reportbuyer.com/product/4644549/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/autologous-cell-therapy-market---global-industry-analysis-size-share-growth-trends-and-forecast-2016---2024-300396236.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook